SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 41.92 |
| Enterprise Value ($M) | 32.68 |
| Book Value ($M) | 4.76 |
| Book Value / Share | 0.17 |
| Price / Book | 8.81 |
| NCAV ($M) | 3.83 |
| NCAV / Share | 0.13 |
| Price / NCAV | 10.95 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.46 |
| Return on Assets (ROA) | -4.90 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.42 |
| Current Ratio | 1.45 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 12.32 |
| Assets | 13.25 |
| Liabilities | 8.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.08 |
| Operating Income | -20.05 |
| Net Income | -20.06 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.19 |
| Cash from Investing | -0.00 |
| Cash from Financing | 23.89 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 45.79 | |
| 13D/A | Rafael Holdings, Inc. | 49.00 | 5.13 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,978 | 28,931 | 6.84 | |
| 17,537 | 5,257 | 333.59 | |
| 15,252 | 8,392 | 181.74 | |
| 7,795 | 11,890 | 65.56 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYCC – Cyclacel Pharmaceuticals, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
| CYRX – Cryoport, Inc. | DARE – Daré Bioscience, Inc. |
| DERM – Journey Medical Corporation |
Financial data and stock pages provided by
Fintel.io